|1.||Oode, Chisato: 1 article (11/2014)|
|2.||Yokota, Mariko: 1 article (11/2014)|
|3.||Iwadate, Takehiro: 1 article (11/2014)|
|4.||Nihei, Ken-ichi: 1 article (11/2014)|
|5.||Shimada, Wataru: 1 article (11/2014)|
|6.||Izutsu, Yukiko: 1 article (11/2014)|
|7.||Azorín-Ortuño, María: 1 article (08/2011)|
|8.||Espín, Juan C: 1 article (08/2011)|
|9.||Tomás-Barberán, Francisco A: 1 article (08/2011)|
|10.||Morales, Juan C: 1 article (08/2011)|
|1.||Body Weight (Weight, Body)
08/01/2011 - "Forty-seven tissues, organs and fluids were analyzed 6 h after intragastric RES administration (5.9 mg/kg body weight) using HPLC-MS/MS. Twelve RES and seven dihydroresveratrol (DH-RES) metabolites were detected. "
02/01/2013 - "After a washout period, all of the subjects received a one-time oral dose of 0.5 mg trans-resveratrol/kg body weight in the form of a grapevine-shoot supplement, and 24-h urine samples were analyzed by liquid chromatography-UV/Vis-MS/MS. Besides dihydroresveratrol, 2 previously unknown bacterial trans-resveratrol metabolites were identified in vitro and in vivo: 3,4'-dihydroxy-trans-stilbene and 3,4'-dihydroxybibenzyl (lunularin). "
|2.||Melanoma (Melanoma, Malignant)
11/24/2014 - "Dihydroresveratrol glucoside 1 isolated from Camellia oleifera and its xyloside derivative 2 were synthesized for the first time in 5 steps from TBS-protected aldehyde 4. Natural product 1 is a potent melanogenesis inhibitor in B16F0 melanoma cells (approximately 40 fold more potent than kojic acid). "
11/24/2014 - "Synthesis of dihydroresveratrol glycosides and evaluation of their activity against melanogenesis in B16F0 melanoma cells."